急重症指南

订阅

MedSci主页 / 所有栏目 / 急重症指南

2021 新加坡高级生命支持指南

2021-08-30 新加坡医学会 Singapore Med J

高级生命支持

2021年新加坡高级生命支持指南是对2016年版指南的更新，高级生命支持（ACLS）强调在复苏过程中使用先进的气道管理和通气、循环支持以及适当的药物应用和确定心脏骤停的可逆原因。

中文标题：

2021 新加坡高级生命支持指南

英文标题：

Singapore Advanced Cardiac Life Support Guidelines 2021

发布机构：

新加坡医学会

发布日期：

2021-08-30

简要介绍：

2021年新加坡高级生命支持指南是对2016年版指南的更新，高级生命支持（ACLS）强调在复苏过程中使用先进的气道管理和通气、循环支持以及适当的药物应用和确定心脏骤停的可逆原因。本文主要针对高级生命支持提供指导。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 新加坡高级生命支持指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=25a291c00231823a, title=2021 新加坡高级生命支持指南, enTitle=Singapore Advanced Cardiac Life Support Guidelines 2021, guiderFrom=Singapore Med J, authorId=0, author=, summary=2021年新加坡高级生命支持指南是对2016年版指南的更新，高级生命支持（ACLS）强调在复苏过程中使用先进的气道管理和通气、循环支持以及适当的药物应用和确定心脏骤停的可逆原因。, cover=https://img.medsci.cn/2022112/1641969119010_1608702.png, journalId=0, articlesId=null, associationId=2285, associationName=新加坡医学会, associationIntro=新加坡医学会(SMA,Singapore Medical Association), copyright=0, guiderPublishedTime=Mon Aug 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年新加坡高级生命支持指南是对2016年版指南的更新，高级生命支持（ACLS）强调在复苏过程中使用先进的气道管理和通气、循环支持以及适当的药物应用和确定心脏骤停的可逆原因。本文主要针对高级生命支持提供指导。</span></p>, tagList=[TagDto(tagId=82772, tagName=高级生命支持)], categoryList=[CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=5, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3663, appHits=51, showAppHits=0, pcHits=301, showPcHits=3612, likes=2, shares=5, comments=5, approvalStatus=1, publishedTime=Wed Jan 12 14:29:41 CST 2022, publishedTimeString=2021-08-30, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Wed Jan 12 14:39:46 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 03:14:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 新加坡高级生命支持指南.pdf)])
2021 新加坡高级生命支持指南.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1200977, encodeId=e7e712009e751, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7ff5644680, createdName=ms3000001204324777, createdTime=Wed Mar 09 18:22:34 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200975, encodeId=bc9712009e56c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7ff5644680, createdName=ms3000001204324777, createdTime=Wed Mar 09 18:22:27 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183532, encodeId=66d1118353208, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/70e28c5f379546819d312bcac8ecc124/f1b01dcf10fc46728cc0eff8ad54139b.jpg, createdBy=d92f5428273, createdName=一颗酸酸的小李子, createdTime=Wed Jan 12 15:02:48 CST 2022, time=2022-01-12, status=1, ipAttribution=)]
    2022-03-09 ms3000001204324777

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1200977, encodeId=e7e712009e751, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7ff5644680, createdName=ms3000001204324777, createdTime=Wed Mar 09 18:22:34 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200975, encodeId=bc9712009e56c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7ff5644680, createdName=ms3000001204324777, createdTime=Wed Mar 09 18:22:27 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183532, encodeId=66d1118353208, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/70e28c5f379546819d312bcac8ecc124/f1b01dcf10fc46728cc0eff8ad54139b.jpg, createdBy=d92f5428273, createdName=一颗酸酸的小李子, createdTime=Wed Jan 12 15:02:48 CST 2022, time=2022-01-12, status=1, ipAttribution=)]
    2022-03-09 ms3000001204324777

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1200977, encodeId=e7e712009e751, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7ff5644680, createdName=ms3000001204324777, createdTime=Wed Mar 09 18:22:34 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200975, encodeId=bc9712009e56c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7ff5644680, createdName=ms3000001204324777, createdTime=Wed Mar 09 18:22:27 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183532, encodeId=66d1118353208, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/70e28c5f379546819d312bcac8ecc124/f1b01dcf10fc46728cc0eff8ad54139b.jpg, createdBy=d92f5428273, createdName=一颗酸酸的小李子, createdTime=Wed Jan 12 15:02:48 CST 2022, time=2022-01-12, status=1, ipAttribution=)]
    2022-01-12 一颗酸酸的小李子

    学习了

    0

相关指南

2021 ERC指南：成人高级生命支持

欧洲复苏委员会(ERC,European Resuscitation Council) · 2021-03-24

2018 美国心脏协会关于心肺复苏及心血管急救指南的重点更新：高级心血管生命支持及儿童高级生命支持（中文翻译版）

AHA 指南重点更新摘要项目组 · 2018-12-20

2018年美国心脏协会心肺复苏与心血管急救指南更新解读—抗心律失常药物在成人心脏骤停高级生命支持及自主循环恢复后的应用

暂未更新 · 2018-11-20

2018 AHA心肺复苏与心血管急救指南：心跳骤停期间和之后应用抗心律失常药物进行高级生命支持（更新）

美国心脏协会(AHA,American Heart Association) · 2018-11-05

2018 AHA心肺复苏与心血管急救指南：儿童高级生命支持（更新）

美国心脏协会(AHA,American Heart Association) · 2018-11-05